CH630257A5 - Sustained release formulation - Google Patents

Sustained release formulation Download PDF

Info

Publication number
CH630257A5
CH630257A5 CH277676A CH277676A CH630257A5 CH 630257 A5 CH630257 A5 CH 630257A5 CH 277676 A CH277676 A CH 277676A CH 277676 A CH277676 A CH 277676A CH 630257 A5 CH630257 A5 CH 630257A5
Authority
CH
Switzerland
Prior art keywords
formulation
present
hydrocolloid
gastric juice
release
Prior art date
Application number
CH277676A
Other languages
German (de)
English (en)
Inventor
Prabhakar Ranchhordas Sheth
Jacques Levon Tossounian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of CH630257A5 publication Critical patent/CH630257A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH277676A 1975-03-17 1976-03-05 Sustained release formulation CH630257A5 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
CH630257A5 true CH630257A5 (en) 1982-06-15

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
CH277676A CH630257A5 (en) 1975-03-17 1976-03-05 Sustained release formulation

Country Status (21)

Country Link
JP (1) JPS51115910A (el)
AR (1) AR222624A1 (el)
AT (1) AT353415B (el)
AU (1) AU505355B2 (el)
CA (1) CA1073358A (el)
CH (1) CH630257A5 (el)
DD (1) DD124102A5 (el)
DE (1) DE2611041A1 (el)
DK (1) DK148344C (el)
ES (1) ES446075A1 (el)
FR (1) FR2304354A1 (el)
GB (1) GB1546448A (el)
GR (1) GR60341B (el)
IE (1) IE43083B1 (el)
LU (1) LU74558A1 (el)
MC (1) MC1101A1 (el)
NL (1) NL190313C (el)
NZ (1) NZ180321A (el)
PH (1) PH14927A (el)
PT (1) PT64907B (el)
SE (1) SE433804B (el)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
JP2626248B2 (ja) * 1991-04-08 1997-07-02 日本新薬株式会社 カプセル剤
ATE173159T1 (de) * 1992-03-25 1998-11-15 Depomed Systems Inc Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
CN1133558A (zh) * 1993-10-29 1996-10-16 雷克特和科尔曼产品有限公司 可发泡的明胶胶囊填充药物
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
WO1995031186A1 (en) * 1994-05-13 1995-11-23 Smithkline Beecham Corporation Method and composition for increasing calcium uptake
JPH10509981A (ja) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル，インコーポレイティド 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (el) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
AR222624A1 (es) 1981-06-15
DD124102A5 (el) 1977-02-02
IE43083L (en) 1976-09-17
DK148344B (da) 1985-06-17
DK113676A (da) 1976-09-18
FR2304354A1 (fr) 1976-10-15
DK148344C (da) 1985-11-04
FR2304354B1 (el) 1979-04-27
JPS638084B2 (el) 1988-02-19
PT64907B (fr) 1978-03-24
AU505355B2 (en) 1979-11-15
AU1204976A (en) 1977-09-22
JPS51115910A (en) 1976-10-13
CA1073358A (en) 1980-03-11
SE7603325L (sv) 1976-09-18
NL190313B (nl) 1993-08-16
GB1546448A (en) 1979-05-23
GR60341B (en) 1978-05-17
AT353415B (de) 1979-11-12
ATA192276A (de) 1979-04-15
NZ180321A (en) 1978-06-20
DE2611041A1 (de) 1976-10-14
ES446075A1 (es) 1977-09-16
MC1101A1 (fr) 1977-02-04
NL190313C (nl) 1994-01-17
NL7602776A (nl) 1976-09-21
LU74558A1 (el) 1977-09-27
DE2611041C2 (el) 1988-06-09
IE43083B1 (en) 1980-12-17
SE433804B (sv) 1984-06-18
PH14927A (en) 1982-01-29
PT64907A (fr) 1976-04-01

Similar Documents

Publication Publication Date Title
DE2611041C2 (el)
DE69821553T2 (de) Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat
DE69022876T2 (de) Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe.
DE69624907T3 (de) Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten
DE3811114C2 (de) Zweischichtige Dosierungsform zur Abgabe eines Wirkstoffs
AT398165B (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung
DE69629797T2 (de) Matrix zur gesteuerten freisetzung von arzneistoffen
DE69230475T2 (de) Verzögerte Freigabe Matrix für Arzneimittel
DE69217191T2 (de) Multipartikel-tablette mit schnellauflösbarkeit
DE69727922T2 (de) Schnell zerfallende orale dosierungsform
DE3780222T2 (de) Pharmazeutische zusammensetzung mit kontrollierter wirkstofffreisetzung.
EP0068191B2 (de) Orale Dipyridamolformen
DE1617374C2 (de) Verfahren zum Herstellen eines pharmazeutischen Präparates mit verzögerter analgetischer Wirkung
DE68904459T2 (de) Antacidzusammensetzungen mit laengerer verweilzeit im magen.
DE3309516C2 (el)
US4167558A (en) Novel sustained release tablet formulations
US4140755A (en) Sustained release tablet formulations
EP0486863B1 (de) Antazida-Zubereitung mit verlängerter Magenverweilzeit
DE60117801T2 (de) Pharmazeutische zusammensetzung mit gesteuerter freigabe und verzögerter absorption
DE69009684T2 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
DE60207383T2 (de) Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen
DE69618934T2 (de) Verbesserte organische zusammensetzungen
DE2808514A1 (de) Nitrofurantoin enthaltende tablette
AT398166B (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen)
CH639845A5 (en) Solid depot pharmaceutical preparations and process for their production

Legal Events

Date Code Title Description
PUE Assignment

Owner name: F. HOFFMANN-LA ROCHE AG

PL Patent ceased